The mission of the Developmental Core is to stimulate and support new HIV/AIDS research at University of Rochester (UR). This mission will be achieved by: catalyzing new collaborative lines of investigation;facilitating recruitment of new HIV/AIDS researchers;creating a stimulating intellectual and scientific environment;promoting the mentoring and training of junior faculty;helping to support international collaborations with partners in South Africa;and providing a mechanism whereby faculty who do not presently work on HIV/AIDS can be successfully """"""""recruited"""""""" to work on this problem. The Core will leverage structures created for the UR's Clinical and Translational Science Institute (CTSI). These include highly effective pilot grant award mechanisms, novel mentoring programs and career development workshops. Five interconnected aims will be pursued.
Aim 1 is to catalyze new multidisciplinary research on HIV/AIDS. This will be achieved by funding pilot awards that support new collaborative efforts in strategically selected """"""""areas of opportunity"""""""" (prevention/behavior, Optics and Nanomedicine, and international collaborations). Support will also be provided for generation of enabling preliminary data for new grant applications and travelling fellowships.
Aim 2 will focus on recruiting new HIV/AIDS investigators. This will be achieved by providing Mentored Investigator Awards patterned on the KO8 mechanism, with the use of experienced mentoring teams to assist young faculty, and by supporting new faculty recruitment.
The third Aim will support mentoring and career development of young HIV/AIDS investigators. This will use the structured mentoring program developed for the UR CTSI. Mentoring partnerships will be supervised by a Mentoring Committee of senior D-CFAR investigators with extensive mentoring experience. A grant facilitation service will also be initiated to provide (i) a forum for discussion and refinement of grant ideas at an early stage and (ii) expert advice and input on written materials, with prompt turn-around.
Aim 4 will create a stimulating intellectual and scientific environment, through new seminar programs including a """"""""Multi-Disciplinary DCFAR"""""""" seminar, and a """"""""HIV/AIDS Research-in-Progress"""""""" (HRIP) seminar;industry collaboration will also be supported. Finally, the fifth aim will focus on international collaborations. Short-term instruction in biostatistics and HIV/AIDS clinical trial design will be provided for international partners in South Africa. In addition, a forum will be created in which UR trainees will work with datasets and research materials from our partners in South Africa, in a mutually beneficial research collaboration. Overall, these activities are expected to strongly enhance the HIV/AIDS research environment at UR.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI078498-05
Application #
8377544
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
2012-05-01
Project End
2013-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
5
Fiscal Year
2012
Total Cost
$415,612
Indirect Cost
$78,634
Name
University of Rochester
Department
Type
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
McMillan, JoEllyn; Szlachetka, Adam; Zhou, Tian et al. (2018) Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques. AIDS :
Hammond, Jennetta W; Qiu, Wen Q; Marker, Daniel F et al. (2018) HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q. Glia 66:2563-2574
Dompreh, Albert; Tang, Xiaoli; Zhou, Jianlin et al. (2018) Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis. Antimicrob Agents Chemother 62:
Leblanc, Natalie M; Mitchell, Jason (2018) Providers' Perceptions of Couples' HIV Testing and Counseling (CHTC): Perspectives From a U.S. HIV Epicenter. Couple Family Psychol 7:22-33
Rice, John D; Johnson, Brent A; Strawderman, Robert L (2018) Modeling the rate of HIV testing from repeated binary data amidst potential never-testers. Biostatistics :
Nunn, Amy; Parker, Sharon; McCoy, Katryna et al. (2018) African American Clergy Perspectives About the HIV Care Continuum: Results From a Qualitative Study in Jackson, Mississippi. Ethn Dis 28:85-92
Sillman, Brady; Bade, Aditya N; Dash, Prasanta K et al. (2018) Creation of a long-acting nanoformulated dolutegravir. Nat Commun 9:443
Ogunbajo, Adedotun; Kershaw, Trace; Kushwaha, Sameer et al. (2018) Barriers, Motivators, and Facilitators to Engagement in HIV Care Among HIV-Infected Ghanaian Men Who have Sex with Men (MSM). AIDS Behav 22:829-839
Piekna-Przybylska, Dorota; Maggirwar, Sanjay B (2018) CD4+ memory T cells infected with latent HIV-1 are susceptible to drugs targeting telomeres. Cell Cycle 17:2187-2203
Ocque, Andrew J; Hagler, Colleen E; Morse, Gene D et al. (2018) Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid. J Pharm Biomed Anal 156:163-169

Showing the most recent 10 out of 192 publications